QLENX | SRUAX | QLENX / SRUAX | |
Total Expense Ratio | 5.58 | 1.43 | 390% |
Annual Report Gross Expense Ratio | 5.59 | 1.43 | 391% |
Fund Existence | 12 years | 9 years | - |
Gain YTD | 15.394 | 5.685 | 271% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 5.17B | 233M | 2,220% |
Annual Yield % from dividends | 6.07 | 1.00 | 609% |
Returns for 1 year | 25.30 | 2.85 | 888% |
Returns for 3 years | 92.59 | 22.58 | 410% |
Returns for 5 years | 178.75 | 44.77 | 399% |
Returns for 10 years | 141.28 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FMCEX | 37.95 | 0.22 | +0.58% |
Fidelity Advisor Stock Selec Mid Cp C | |||
PRHSX | 77.94 | 0.43 | +0.55% |
T. Rowe Price Health Sciences | |||
WGFIX | 11.86 | N/A | N/A |
William Blair Global Leaders I | |||
WRAAX | 13.77 | -0.01 | -0.07% |
Wilmington Global Alpha Equities A | |||
AWWIX | 15.54 | -0.02 | -0.13% |
CIBC Atlas International Growth Instl |